Researchers use custom molecule to halt growth of multiple myeloma and diffuse large B cell lymphoma in mice
Perinatal depression: Our study shows how common it is for both parents to experience it
26 July 2022Veterans Health Administration aims to reduce benzodiazepine prescriptions for people 75 and older
26 July 2022Researchers use custom molecule to halt growth of multiple myeloma and diffuse large B cell lymphoma in mice
Researchers at Stanford University have developed “decoy receptor” molecules that inhibit the growth of both multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in mice. The molecules, described in a study to be published July 26 in the Journal of Experimental Medicine (JEM), were also found to be nontoxic in monkeys, suggesting they could be used to treat humans with either of these deadly diseases, which are two of the most common blood cancers around the world.
